Cargando…
ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies
SIMPLE SUMMARY: Mounting evidence show that dedifferentiated and undifferentiated endometrial and ovarian carcinomas (DDC/UDC) are clinically distinct entities with rapid progression, poor response to adjuvant therapy, and grim outcome, even when compared to other high-grade gynecologic malignancies...
Autor principal: | Tessier-Cloutier, Basile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486746/ https://www.ncbi.nlm.nih.gov/pubmed/37686505 http://dx.doi.org/10.3390/cancers15174229 |
Ejemplares similares
-
An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group
por: Shigeta, Shogo, et al.
Publicado: (2023) -
Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma
por: Hamilton, Sarah Nicole, et al.
Publicado: (2022) -
Dedifferentiated Giant-Cell Tumor of Bone with an Undifferentiated Round Cell Mesenchymal Component
por: Estrada-Villaseñor, Eréndira G., et al.
Publicado: (2014) -
SWI/SNF‐deficiency defines highly aggressive undifferentiated endometrial carcinoma
por: Tessier‐Cloutier, Basile, et al.
Publicado: (2020) -
The roles of ARID1A in gynecologic cancer
por: Mao, Tsui-Lien, et al.
Publicado: (2013)